Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Liabilities (2016 - 2025)

STRATA Skin Sciences' Total Liabilities history spans 14 years, with the latest figure at $29.4 million for Q3 2025.

  • For Q3 2025, Total Liabilities fell 1.93% year-over-year to $29.4 million; the TTM value through Sep 2025 reached $29.4 million, down 1.93%, while the annual FY2024 figure was $30.0 million, 2.14% up from the prior year.
  • Total Liabilities for Q3 2025 was $29.4 million at STRATA Skin Sciences, up from $29.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $38.3 million in Q2 2023 and bottomed at $19.1 million in Q2 2021.
  • The 5-year median for Total Liabilities is $29.8 million (2023), against an average of $28.6 million.
  • The largest annual shift saw Total Liabilities soared 63.6% in 2022 before it dropped 23.61% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $21.2 million in 2021, then surged by 43.73% to $30.4 million in 2022, then decreased by 3.66% to $29.3 million in 2023, then rose by 2.14% to $30.0 million in 2024, then dropped by 1.85% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Total Liabilities are $29.4 million (Q3 2025), $29.0 million (Q2 2025), and $30.1 million (Q1 2025).